Discovery of novel benzamide derivatives bearing benzamidophenyl and phenylacetamidophenyl scaffolds as potential antitumor agents via targeting PARP-1-Reference-Cited by-同舟云学术

Discovery of novel benzamide derivatives bearing benzamidophenyl and phenylacetamidophenyl scaffolds as potential antitumor agents via targeting PARP-1

Published:2023-05 Issue: Volume:251 Page:115243
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Lu Guoqing,Nie Wenxing,Xin Meixiu,Meng Yingfen,Jiang Jiayao,Gu Jiayi,Cheng Xinyi,Chan Albert S.C.,Zou Yong^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference42 articles.

1. An update on poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors: opportunities and challenges in cancer therapy;Wang;J. Med. Chem.,2016

2. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials;Yuan;Cancer Lett.,2017

3. Ribosome ADP-ribosylation inhibits translation and maintains proteostasis in cancers;Challa;Cell,2021

4. Discovery of novel bromophenol-thiosemicarbazone hybrids as potent selective inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) for use in cancer;Guo;J. Med. Chem.,2019

5. Poly(ADP-ribose) polymerase inhibition: past, present and future;Curtin;Nat. Rev. Drug Discov.,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbamoylation at C-8 position of natural 3-arylcoumarin scaffold for the discovery of novel PARP-1 inhibitors with potent anticancer activity;European Journal of Medicinal Chemistry;2024-11

2. An update on small molecule compounds targeting synthetic lethality for cancer therapy;European Journal of Medicinal Chemistry;2024-11

3. The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer;Medicinal Research Reviews;2024-08-24

4. Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship;European Journal of Medicinal Chemistry;2024-08

5. Targeting selective inhibitors of PARPs in drug discovery and development;Medicinal Chemistry Research;2024-07-28